Work

81 Gideon (global Investigation of Therapeutic Decisions in Hcc and of Its Treatment With Sorafenib) Study First Interim Results: Sorafenib Dosing Across Regions and Disease Subgroups

FWCI: 0.54
Cites:
Cited by: 5
Related to: 10